CJC‑1295 sits at the intersection of peptide chemistry and endocrine pharmacology, making it a focal point for researchers investigating growth hormone (GH) regulation, receptor signaling, and translational pharmacokinetics. As a synthetic growth hormone–releasing hormone (GHRH) analog, it is widely evaluated for its capacity to modulate the GH/IGF‑1 axis in tightly controlled laboratory settings. With expanding …